Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for XPR. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: XPR is a Strong Sell candidate.
XPR stock price ended at $0.002732 on 星期日, after dropping 3.17%
On Dec 21, 2025 00:00, the price of XPR fell by 3.17%, dropping from $0.002719 to $0.002732 with 24h trading volume reaching $2.2M XPR.
